From the FDA: Limitations of Toxoplasma IgM commercial test kits | The Journal of the American Osteopathic Association

Free

News | September 1997

From the FDA: Limitations of Toxoplasma IgM commercial test kits

Article Information

The Journal of the American Osteopathic Association, September 1997, Vol. 97, 506C. doi:10.7556/jaoa.1997.97.9.506C

- Email
- Facebook
- Linkedin
- Twitter
- CiteULike
- Get Permissions
- Get Citation
  Citation
  
  From the FDA: Limitations of Toxoplasma IgM commercial test kits . J Am Osteopath Assoc 1997;97(9):506C. doi: 10.7556/jaoa.1997.97.9.506C.
  
  Download citation file:
  - Ris (Zotero)
  - EndNote
  - BibTex
  - Medlars
  - ProCite
  - RefWorks
  - Reference Manager
  © 2019
  ×
- Alerts
  
  User Alerts
  
  You are adding an alert for:
  
  From the FDA: Limitations of Toxoplasma IgM commercial test kits
  
  You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
  
  The alert will be sent to:
  
  Confirm
  
  ×
  
  This feature is available to Subscribers Only
  Sign In or Subscribe ×